UY28891A1 - Formulacion en aerosol para la inhalacion de beta-agonistas - Google Patents

Formulacion en aerosol para la inhalacion de beta-agonistas

Info

Publication number
UY28891A1
UY28891A1 UY28891A UY28891A UY28891A1 UY 28891 A1 UY28891 A1 UY 28891A1 UY 28891 A UY28891 A UY 28891A UY 28891 A UY28891 A UY 28891A UY 28891 A1 UY28891 A1 UY 28891A1
Authority
UY
Uruguay
Prior art keywords
inhalation
aerosol formulation
agonists
beta
radicals
Prior art date
Application number
UY28891A
Other languages
English (en)
Inventor
Michael Aven
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34979667&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=UY28891(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Publication of UY28891A1 publication Critical patent/UY28891A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/536—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines ortho- or peri-condensed with carbocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/04—Amoebicides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

Abstract

La presente invención se refiere a una formulación en aerosol sin gas propelente que contiene uno o varios compuestos de la fórmula general 1 en la que los radicales R1, R2, R3 y X- pueden tener los significados mencionados en las reivindicaciones y en la descripción, para la inhalación.
UY28891A 2004-05-14 2005-05-11 Formulacion en aerosol para la inhalacion de beta-agonistas UY28891A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE102004024452A DE102004024452A1 (de) 2004-05-14 2004-05-14 Aerosolformulierung für die Inhalation von Betaagonisten

Publications (1)

Publication Number Publication Date
UY28891A1 true UY28891A1 (es) 2005-12-30

Family

ID=34979667

Family Applications (1)

Application Number Title Priority Date Filing Date
UY28891A UY28891A1 (es) 2004-05-14 2005-05-11 Formulacion en aerosol para la inhalacion de beta-agonistas

Country Status (26)

Country Link
EP (1) EP1809293B1 (es)
JP (1) JP4620730B2 (es)
KR (1) KR101288791B1 (es)
CN (1) CN101056640A (es)
AR (1) AR049096A1 (es)
AU (1) AU2005244414B2 (es)
BR (1) BRPI0511135B8 (es)
CA (1) CA2564379C (es)
DE (1) DE102004024452A1 (es)
DK (1) DK1809293T3 (es)
EA (1) EA012583B1 (es)
EC (1) ECSP067004A (es)
ES (1) ES2575925T3 (es)
HU (1) HUE027780T2 (es)
IL (1) IL179218A (es)
MX (1) MXPA06013216A (es)
MY (1) MY148403A (es)
NO (1) NO20065030L (es)
PE (1) PE20060311A1 (es)
PL (1) PL1809293T3 (es)
SG (1) SG152265A1 (es)
TW (1) TWI356703B (es)
UA (1) UA87312C2 (es)
UY (1) UY28891A1 (es)
WO (1) WO2005110421A2 (es)
ZA (1) ZA200607462B (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7056916B2 (en) 2002-11-15 2006-06-06 Boehringer Ingelheim Pharma Gmbh & Co. Kg Medicaments for the treatment of chronic obstructive pulmonary disease
US7220742B2 (en) 2004-05-14 2007-05-22 Boehringer Ingelheim International Gmbh Enantiomerically pure beta agonists, process for the manufacture thereof and use thereof as medicaments
ES2530991T3 (es) 2005-08-15 2015-03-09 Boehringer Ingelheim Int Procedimiento para la obtención de betamiméticos
AU2006311060A1 (en) * 2005-11-09 2007-05-18 Boehringer Ingelheim International Gmbh Aerosolformulation for inhalation
UY30543A1 (es) * 2006-08-18 2008-03-31 Boehringer Ingelheim Int Formulacion de aerosol para la inhalacion de beta- agonistas
CA2738616A1 (en) * 2008-11-21 2010-05-27 Boehringer Ingelheim International Gmbh Aerosol formulation for the inhalation of beta agonists
JP2012509299A (ja) * 2008-11-21 2012-04-19 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング β作用薬吸入用のエアロゾル製剤
WO2014056840A1 (en) 2012-10-09 2014-04-17 Boehringer Ingelheim International Gmbh Beta-2-adrenoceptor agonist for the treatment of cough
EP3551187B1 (en) 2016-12-12 2021-02-17 Boehringer Ingelheim International GmbH Nintedanib for use in methods for the treatment of interstitial lung diseases by coadministration with olodaterol

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3134590A1 (de) * 1981-09-01 1983-03-10 Boehringer Ingelheim KG, 6507 Ingelheim Neue benzo-heterocyclen
US4460581A (en) * 1982-10-12 1984-07-17 Boehringer Ingelheim Kg (1-Hydroxy-2-amino-alkyl)-substituted benzoxazinones and benzoxazolinones
JPH0637388B2 (ja) * 1986-02-17 1994-05-18 千寿製薬株式会社 水性液剤
GB9405019D0 (en) * 1994-03-15 1994-04-27 Smithkline Beecham Plc Novel compounds
DE10253282A1 (de) * 2002-11-15 2004-05-27 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Arzneimittel zur Behandlung von chronisch obstruktiver Lungenerkrankung
DE102004019539A1 (de) * 2004-04-22 2005-11-10 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Arzneimittel zur Behandlung von Atemwegserkrankungen
ATE539754T1 (de) * 2004-04-22 2012-01-15 Boehringer Ingelheim Int Arzneinmittelkombinationen enthaltend benzoxazine zur behandlung von atemwegserkrankungen
DE102004024451A1 (de) * 2004-05-14 2005-12-22 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pulverformulierungen für die Inhalation, die Enantiomerenreine Betaagonisten enthalten
DE102004024454A1 (de) * 2004-05-14 2005-12-08 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Enantiomerenreine Betaagonisten, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel

Also Published As

Publication number Publication date
PE20060311A1 (es) 2006-05-08
AU2005244414A1 (en) 2005-11-24
BRPI0511135B8 (pt) 2021-05-25
JP4620730B2 (ja) 2011-01-26
WO2005110421A2 (de) 2005-11-24
IL179218A0 (en) 2007-03-08
AU2005244414B2 (en) 2010-12-09
ECSP067004A (es) 2007-02-28
MXPA06013216A (es) 2007-02-08
DK1809293T3 (en) 2016-06-20
AR049096A1 (es) 2006-06-28
TW200608981A (en) 2006-03-16
EP1809293A2 (de) 2007-07-25
SG152265A1 (en) 2009-05-29
KR20070022084A (ko) 2007-02-23
WO2005110421A3 (de) 2006-03-16
IL179218A (en) 2012-10-31
HUE027780T2 (en) 2016-11-28
EP1809293B1 (de) 2016-03-16
ES2575925T3 (es) 2016-07-04
KR101288791B1 (ko) 2013-07-29
PL1809293T3 (pl) 2016-09-30
EA012583B1 (ru) 2009-10-30
JP2007537188A (ja) 2007-12-20
CN101056640A (zh) 2007-10-17
UA87312C2 (ru) 2009-07-10
ZA200607462B (en) 2008-06-25
DE102004024452A1 (de) 2005-12-08
EA200602017A1 (ru) 2007-06-29
NO20065030L (no) 2006-11-30
BRPI0511135B1 (pt) 2019-11-12
CA2564379C (en) 2013-07-30
CA2564379A1 (en) 2005-11-24
BRPI0511135A (pt) 2007-11-27
MY148403A (en) 2013-04-30
TWI356703B (en) 2012-01-21

Similar Documents

Publication Publication Date Title
UY29844A1 (es) Formulación en aerosol para la inhalación de beta-agonistas
UY28891A1 (es) Formulacion en aerosol para la inhalacion de beta-agonistas
UY30543A1 (es) Formulacion de aerosol para la inhalacion de beta- agonistas
UY30542A1 (es) Formulacion de aerosol para la inhalacion de agonistas beta
CY1117324T1 (el) Παραγωγα 1-φαινυλ-2-πυριδινυλ αλκυλ αλκοολων ως αναστολεις φωσφοδιεστερασης
CO6160235A2 (es) Isoxazolinas insecticidas
UY29886A1 (es) Derivados de pirazol novedosos, composiciones farmaccuticas que los contienen, procedimientos para la preparacinn de los mismos y aplicaciones
ECSP066541A (es) Nuevos derivados de piridazin-3(2h)-ona
CR11106A (es) Inhibidores de cinasa p710 s6
DK1483265T3 (da) Purinderivater som kinaseinhibitorer
CY1109916T1 (el) Βενζιμιδαζολο-θειοφαινικες ενωσεις ως plk αναστολεις
IL185275A0 (en) N-sulphonylpyrrole derivatives and pharmaceutical compositions containing the same
ATE479687T1 (de) Kinaseinhibitoren
CO6270311A2 (es) Derivados bis-(sulfonilamino) en terapia 066
CR8986A (es) Isoxazoles sustituidos como fungicidas
CR7956A (es) Oxazolidinonas de indolona antibacterial intermedios para su preparacion y composiciones farmaceuticas que contienen los mismos
NO20061317L (no) Imidazopyridinderivater som induserbare NO-syntaseinhibatorer
HRP20080529T3 (en) Amide prodrug of gemcitabine, compositions and use thereof
UY29510A1 (es) Derivados de urea, metodos para su fabricación, y usos de los mismos
CR9391A (es) Derivados de indanil-piperazinas, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen
UY30555A1 (es) Formulacion aerosol para la inhalacion de beta-agonistas
NO20061344L (no) Imidazopyridinderivater som induserbare NO-syntaseoinhibitorer
NO20061316L (no) Imidazopyndinderivater som induserbare NO-syntaseinhibitorer
EA200801139A1 (ru) Композиция для аэрозольной ингаляции
GT200600173A (es) Forma purificada de tranaproget

Legal Events

Date Code Title Description
109 Application deemed to be withdrawn

Effective date: 20160617